A lawsuit was filed on behalf of investors in Vivint Solar Inc (NYSE:VSLR) shares over alleged securities laws violations. Deadline: January 20, 2015. NYSE:VSLR investors should contact the Shareholders Foundation at [email protected] Vivint Solar, Inc. (NYSE:VSLR) belongs to Technology sector. Its net profit margin is -91.70% and weekly performance is 1.00%. On last trading day company shares ended up $9.12. Vivint Solar, Inc. (NYSE:VSLR) distance from 50-day simple moving average (SMA50) is -25.97%.
Avon Products (NYSE:AVP) saw a significant increase in short interest in November. As of November 14th, there was short interest totalling 48,314,552 shares, an increase of 7.1% from the October 31st total of 45,101,438 shares, ARN reports. Avon Products Inc. (NYSE:AVP) shares advanced 0.93% in last trading session and ended the day at $9.79. AVP Gross Margin is 60.60% and its return on assets is -4.70%. Avon Products Inc. (NYSE:AVP) quarterly performance is -25.27%.
EQT Corporation (EQT: Quote) announced its 2015 capital expenditure or CAPEX forecast of $2.5 billion, excluding business development and land acquisitions. The CAPEX forecast includes $2.3 billion for EQT Production and $225 to $250 million for EQT Midstream depending on the timing of an expected drop-down. EQT Corporation (NYSE:EQT) belongs to Basic Materials sector. Its net profit margin is 25.30% and weekly performance is -11.98%. On last trading day company shares ended up $80.52. EQT Corporation (NYSE:EQT) distance from 50-day simple moving average (SMA50) is -10.62%.
Toyota Motor Corporation (NYSE:TM) widened a U.S. recall of its vehicles linked to defective air bags to include some of the same models in Japan and China, after one of the devices ruptured in a car at a scrapyard in its home country. Toyota Motor Corporation (NYSE:TM) shares moved down -0.47% in last trading session and ended the day at $128.42. TM Gross Margin is 19.40% and its return on assets is 4.70%. Toyota Motor Corporation (NYSE:TM) quarterly performance is 11.65%.
Cardiovascular Systems, Inc. (NASDAQ:CSII), announced that it has completed enrollment in Japan for its Coronary Orbital Atherectomy System Trial (COAST) study. Taking place in both Japan and the United States, the study is designed to assess the safety and efficacy, as well as economic outcomes, of CSI’s new investigational micro crown Orbital Atherectomy System (OAS) in treating severely calcified coronary lesions in patients suffering from Coronary Artery Disease (CAD). Cardiovascular Systems Inc. (NASDAQ:CSII) ended the last trading day at $29.03. Company weekly volatility is calculated as 2.66% and price to cash ratio as 7.84. Cardiovascular Systems Inc. (NASDAQ:CSII) showed a weekly performance of -1.86%.